Molecular genetics of colorectal cancer
- PMID: 21090969
- DOI: 10.1146/annurev-pathol-011110-130235
Molecular genetics of colorectal cancer
Abstract
Over the past three decades, molecular genetic studies have revealed some critical mutations underlying the pathogenesis of the sporadic and inherited forms of colorectal cancer (CRC). A relatively limited number of oncogenes and tumor-suppressor genes-most prominently the APC, KRAS, and p53 genes-are mutated in a sizeable fraction of CRCs, and a larger collection of genes that are mutated in subsets of CRC have begun to be defined. Together with DNA-methylation and chromatin-structure changes, the mutations act to dysregulate conserved signaling networks that exert context-dependent effects on critical cell phenotypes, including the regulation of cellular metabolism, proliferation, differentiation, and survival. Much work remains to be done to fully understand the nature and significance of the individual and collective genetic and epigenetic defects in CRC. Some key concepts for the field have emerged, two of which are emphasized in this review. Specifically, the gene defects in CRC often target proteins and pathways that exert pleiotropic effects on the cancer cell phenotype, and particular genetic and epigenetic alterations are linked to biologically and clinically distinct subsets of CRC.
Similar articles
-
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.Gastroenterology. 2005 Jul;129(1):156-69. doi: 10.1053/j.gastro.2005.03.051. Gastroenterology. 2005. PMID: 16012945
-
Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.Oncotarget. 2016 Dec 20;7(51):84003-84016. doi: 10.18632/oncotarget.11510. Oncotarget. 2016. PMID: 27563825 Free PMC article.
-
Lessons from hereditary colorectal cancer.Cell. 1996 Oct 18;87(2):159-70. doi: 10.1016/s0092-8674(00)81333-1. Cell. 1996. PMID: 8861899 Review. No abstract available.
-
Progressing toward a molecular description of colorectal cancer development.FASEB J. 1992 Jul;6(10):2783-90. doi: 10.1096/fasebj.6.10.1321771. FASEB J. 1992. PMID: 1321771 Review.
-
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.Br Med Bull. 2002;64:27-43. doi: 10.1093/bmb/64.1.27. Br Med Bull. 2002. PMID: 12421723 Review.
Cited by
-
Animal models of colorectal cancer.Cancer Metastasis Rev. 2013 Jun;32(1-2):39-61. doi: 10.1007/s10555-012-9404-6. Cancer Metastasis Rev. 2013. PMID: 23076650 Free PMC article. Review.
-
Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes.Discov Oncol. 2024 Sep 18;15(1):457. doi: 10.1007/s12672-024-01298-1. Discov Oncol. 2024. PMID: 39292326 Free PMC article.
-
Mouse models of Kras activation in gastric cancer.Exp Mol Med. 2022 Nov;54(11):1793-1798. doi: 10.1038/s12276-022-00882-1. Epub 2022 Nov 11. Exp Mol Med. 2022. PMID: 36369466 Free PMC article. Review.
-
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.Oncogene. 2012 Oct 4;31(40):4409-19. doi: 10.1038/onc.2011.609. Epub 2012 Jan 16. Oncogene. 2012. PMID: 22249255 Free PMC article.
-
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.Cancer. 2016 Sep 15;122(18):2828-35. doi: 10.1002/cncr.30082. Epub 2016 May 31. Cancer. 2016. PMID: 27244218 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
